Ellard; John Mark
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ellard; John Mark.The latest application filed is for "heteroaryl plasma kallikrein inhibitors".
- Ellard; John Mark - Buntingford GB
- Ellard; John Mark - Royston GB
- Ellard; John Mark - Hatfield GB
- Ellard; John Mark - Cambridge GB
| Patent | Date |
|---|---|
| Heteroaryl Plasma Kallikrein Inhibitors App 20220298176 - Papaioannou; Nikolaos ; et al. | 2022-09-22 |
| Heteroaryl plasma kallikrein inhibitors Grant 11,370,803 - Papaioannou , et al. June 28, 2 | 2022-06-28 |
| Inhibitors of plasma kallikrein and uses thereof Grant 11,352,356 - Papaioannou , et al. June 7, 2 | 2022-06-07 |
| Plasma Kallikrein Inhibitors And Uses Thereof App 20210078999 - Papaioannou; Nikolaos ; et al. | 2021-03-18 |
| Heteroaryl Plasma Kallikrein Inhibitors App 20210079022 - Papaioannou; Nikolaos ; et al. | 2021-03-18 |
| Inhibitors Of Plasma Kallikrein And Uses Thereof App 20200317667 - Papaioannou; Nikolaos ; et al. | 2020-10-08 |
| Inhibitors of plasma kallikrein and uses thereof Grant 10,730,874 - Papaioannou , et al. | 2020-08-04 |
| Inhibitors Of Plasma Kallikrein And Uses Thereof App 20190284182 - Papaioannou; Nikolaos ; et al. | 2019-09-19 |
| Oxazole tyrosine kinase inhibitors Grant 9,187,465 - Reader , et al. November 17, 2 | 2015-11-17 |
| Fused aminodihydro-oxazine derivatives Grant 9,079,914 - Ellard , et al. July 14, 2 | 2015-07-14 |
| Oxazole Tyrosine Kinase Inhibitors App 20150057282 - READER; John Charles ; et al. | 2015-02-26 |
| Oxazole tyrosine kinase inhibitors Grant 8,921,544 - Reader , et al. December 30, 2 | 2014-12-30 |
| Oxazole Tyrosine Kinase Inhibitors App 20140275041 - READER; John Charles ; et al. | 2014-09-18 |
| Oxazole Tyrosine Kinase Inhibitors App 20130102592 - READER; John Charles ; et al. | 2013-04-25 |
| Oxazole tyrosine kinase inhibitors Grant 8,378,095 - Reader , et al. February 19, 2 | 2013-02-19 |
| Fused Aminodihydro-oxazine Derivatives App 20120202804 - Ellard; John Mark ; et al. | 2012-08-09 |
| Oxazole Tyrosine Kinase Inhibitors App 20100298301 - Reader; John Charles ; et al. | 2010-11-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 